Virtual Coach for Weight Loss in Ventral Hernia Patients
What You Need to Know Before You Apply
What is the purpose of this trial?
This trial tests a virtual coach designed to help patients lose weight before ventral hernia surgery. The researchers aim to determine if the MyChart-enabled virtual weight loss coach results in greater weight loss than standard tools, potentially reducing hospital readmissions. The trial is open to individuals diagnosed with obesity (BMI of 30 or higher) who are scheduled for ventral hernia surgery. Participants will either use the virtual coach or follow standard weight loss methods, with their progress tracked over six months. As an unphased trial, this study provides participants the chance to explore innovative weight loss methods that could improve surgical outcomes.
Will I have to stop taking my current medications?
The trial does not specify if you need to stop taking your current medications. However, if you are on psychiatric medications associated with weight gain or long-term steroid therapy, you may not be eligible to participate.
What prior data suggests that this virtual coach is safe for weight loss in ventral hernia patients?
Research shows that virtual health coaching programs are generally safe and easy to use. In studies of similar programs, most patients reported positive experiences and few side effects. These virtual coaches assist people in managing their weight and health from home, offering both convenience and safety. The MyChart-enabled virtual coach aims to aid weight loss before surgery, potentially reducing the risk of complications. Although specific safety data for this exact program is not yet available, similar digital health tools have demonstrated safety. As this trial does not involve medication or surgery, the risks are lower compared to more invasive treatments.12345
Why are researchers excited about this trial?
Researchers are excited about the virtual coach for weight loss in ventral hernia patients because it offers a personalized, tech-enabled approach that standard weight loss tools lack. Unlike traditional methods, which often involve generic advice and in-person sessions, this virtual coach utilizes MyChart to deliver tailored guidance and support directly to patients' devices. This innovative delivery method allows for real-time adjustments and ongoing motivation, making weight loss more accessible and potentially more effective for preoperative patients.
What evidence suggests that this virtual coach is effective for weight loss in ventral hernia patients?
Research shows that virtual coaching can effectively aid weight loss. Studies have found that losing 5-10% of body weight before hernia surgery can reduce surgical risks. Another study found that virtual health coaching can also assist with weight loss after surgery. In this trial, participants in one arm will use the MyChart-enabled virtual coach, designed to support ventral hernia patients in losing weight before surgery. This method may prove more effective than standard weight loss methods used by participants in the other arm.12467
Who Is on the Research Team?
Jana Sacco, MD
Principal Investigator
Assistant Professor
Are You a Good Fit for This Trial?
This trial is for adults aged 18-90 with obesity (BMI of 30+) who are planning to have elective ventral hernia repair surgery. They must be diagnosed with Obesity (ICD Code: E66.9) and have a complete medical record for statistical analysis.Inclusion Criteria
Timeline for a Trial Participant
Screening
Participants are screened for eligibility to participate in the trial
Preoperative Weight Loss
Participants utilize either a MyChart-enabled virtual coach or standard weight loss tools to aid preoperative weight loss
Follow-up
Participants are monitored for weight change, quality of life, and satisfaction with the virtual coach
What Are the Treatments Tested in This Trial?
Interventions
- MyChart enabled virtual weight loss coach
- Standard preoperative weight loss tools
Find a Clinic Near You
Who Is Running the Clinical Trial?
University of Florida
Lead Sponsor
National Center for Advancing Translational Sciences (NCATS)
Collaborator